Global Blood Fund

“Form 990, part iii, line 4 global blood funds activity remained mission-centric during 2017, but once again broadened and deepened in terms of transaction count, activity type, geographic regions supported and partners engaged. Mexico emerged as a strong partner for receiving donated u.s. Equipment and gbf invested in storage facilities in the border town of el paso to facilitate export/import. The charity increased headcount in the final quarter of the calendar year in a move expected to build stronger stakeholder relationships and revenue generating opportunities during 2018. Expenses and revenues where relevant - are listed against program areas. Non-directed grants are considered general income and are not allocated to specific programs. Note that much of gbfs activity involves facilitating cooperation between developed blood services and other agencies (industry suppliers; professional associations etc.) and those less-developed organizations in need of support. Program expenses therefore do not reflect the full "value added" of the charity's operations, which is a significant multiple of funds expended. For example, bloodmobiles donated through gbf (see below) were assessed at a used value of $100,000 each, but cost less than 10% of this sum to ship to a new home in africa/asia: the return on investment ratio (dollars spent to value-added) in this instance is in excess of 1:10, typically the minimum the charity expects to achieve.”

“Form 990, part iii, line 4d a. Expansion of partnership network much of gbfs activity relates to its ability to create and galvanize networks in the u.s. And europe (national and regional blood services, industry suppliers, regulatory bodies etc.) to assist developing blood collection organizations. Working both directly and through pan-national and professional associations, gbf is able to assemble multi-agency collaborations, with objectives and configurations differing by project. Gbf continues to work through its network of partners (aabb in the u.s., isbt internationally and regional professional associations in asia, africa and latin america) to identify opportunities to provide support and offer local assurance that such support is successfully delivered and sustainable. B. Hurricane emergency relief funds and u.s. Blood center employee hurricane damage recovery support in response to the devastation of hurricanes harvey and erma in 2017, gbf served as a collection point for u.s. Based blood centers and vendors to provide support to employees of blood centers with employees impacted. Gbf partnered with blood centers of america to communicate the needs of impacted employees, collect the donation and appropriately distribute funds to the nonprofit community blood centers for direct distribution to employees.”

“Form 990, part iv, line 14a gbf established a u.k. Based office in london where the contract executive director is located. Activities in the london office include grant writing, administration and development of infrastructure to facilitate the transfer of equipment to developing countries.”

“Form 990, part v, line 4a to support the u.k. Office, the company established a banking account to receive donations and pay operating expenses. All transactions into and from the account are controlled by board members of the organization from the u.s.”

“Form 990, part vi, lines 6 and 7a obi holding company is the sole member of gbf and has the authority to appoint board members.”

“Form 990, part vi, line 11b gbf's form 990 is prepared by an independent accounting firm and reviewed internally prior to distributing to the board. Subsequent to review, all updates are incorporated into the form 990 and are provided to board members prior to filing with the irs.”

“Form 990, part vi, line 12c gbf has a conflict of interest policy that establishes guidelines and procedures applicable to transactions or arrangements that might benefit the private interest of an officer or trustee of the organization. Individuals considering a transaction shall appoint a disinterested person to investigate alternatives to the proposed transaction. If a more advantageous transaction or arrangement is not reasonably attainable under the circumstances that would not give rise to a conflict of interest, the board or committee shall determine, by a majority vote of the disinterested trustees, whether the transaction or arrangement is in the best interest of the organization and whether the transaction is fair to the organization. Each trustee, officer, and member of a committee with board delegated powers shall annually sign a statement which affirms that such a person has received a copy of the conflict of interest policy, has read and understands the policy, has agreed to comply with the policy and understands that the organization is a charitable organization and that in order to maintain its federal tax exemption, it must engage primarily in activities which accomplish one or more of its tax-exempt purposes. If the board or the committee has reasonable cause to believe that an interested person has failed to disclose a conflict of interest as required by this policy, the board or committee shall inquire, investigate and take appropriate disciplinary and corrective action, as necessary.”

“Form 990, Part VI, Section C, Lines 15a and 15b The volunteer board members and officers are compensated by a related organization. No part of the related entity compensation is for services rendered to the filing organization. The executive compensation for those individuals is paid by a related organization (Oklahoma Blood Institute - "OBI") of Global Blood Funds sole corporate member. The OBI policy is as follows: As leaders of the states largest biopharmaceutical organization, a 900-plus staff entity, the roles of CEO and other physicians and executives require a rare blend of astute organizational leadership, vision, fiduciary management, advanced medical specialization and expertise in the unique scientific field of transfusion medicine. Executives have responsibility for fifteen operational facilities across three states and ten major markets in the region and the day-to-day provision of a safe and sufficient blood supply to meet the needs of patients in more than 223 facilities served. The compensation of the CEO is determined by the Executive Committee of the Board of Directors comprising community leaders, business executives and physicians with exemplary ethical and fiduciary standards. CEO compensation is based on comparative salary data from similar health care organizations using IRS Form 990s and industry salary surveys. Similarly, compensation for executives reporting to the CEO is proposed by the CEO based on comparable national and local salaries for positions and approved by the Executive Committee. Changes to compensation are reviewed and formally approved annually by the Executive Committee of the Board of Directors. Global Blood Fund's contract executive director is an independent contractor. His compensation is reviewed and approved by the board.”

“Form 990, part vi, line 19 the governing documents are made available upon request.”